Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma.

J Korean Med Sci · 2019 · PMC6786962 · PMID 31602824

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

borderline significanceP = 0.092so close (0.05 < p ≤ 0.1)

However, when analysis was confined to patients with MYCN amplified tumors, NT-3 expression was associated with better early treatment response with borderline significance ( P = 0.092) and higher PFS (86.9% vs. 58.2%; P = 0.044).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.